The impact of diabetes mellitus on treatment and outcomes of rheumatoid arthritis at 5-year follow-up: results from a multi-ethnic Asian cohort.
diabetes mellitus
outcomes
rheumatoid arthritis
treatment
Journal
Rheumatology advances in practice
ISSN: 2514-1775
Titre abrégé: Rheumatol Adv Pract
Pays: England
ID NLM: 101736676
Informations de publication
Date de publication:
2021
2021
Historique:
received:
26
03
2021
accepted:
11
10
2021
entrez:
15
11
2021
pubmed:
16
11
2021
medline:
16
11
2021
Statut:
epublish
Résumé
We evaluated the impact of type 2 diabetes mellitus (T2DM) on RA treatment and outcomes in a longitudinal RA cohort. We analysed data collected in the period 2001-2013 involving 583 RA patients, including demographics, diabetes diagnosis, clinical features, treatment, ACR functional class, HAQ, and quality-of-life measurement using the Short-Form 36. Seventy-seven (13.2%) of the RA patients had T2DM. DAS28 was not different in patients with T2DM at 5 years post-RA diagnosis. Fewer T2DM patients received MTX than those without T2DM (51% Fewer patients with T2DM received MTX compared with those without T2DM. Patients with RA and T2DM were at higher risk of knee arthroplasty than RA patients without T2DM.
Identifiants
pubmed: 34778702
doi: 10.1093/rap/rkab077
pii: rkab077
pmc: PMC8578689
doi:
Types de publication
Journal Article
Langues
eng
Pagination
rkab077Investigateurs
Andrea Ang
(A)
Angela Li-Huan Chan
(AL)
Grace Yin Lai Chan
(GYL)
Madelynn Tsu-Li Chan
(MT)
Faith Li-Ann Chia
(FL)
Hiok Hee Chng
(HH)
Choon Guan Chua
(CG)
Hwee Siew Howe
(HS)
Ee Tzun Koh
(ET)
Li Wearn Koh
(LW)
Kok Ooi Kong
(KO)
Weng Giap Law
(WG)
Samuel Lee Shang Ming
(SLS)
Khai Pang Leong
(KP)
Tsui Yee Lian
(TY)
Xin Rong Lim
(XR)
Jess Mung Ee Loh
(JME)
Mona Manghani
(M)
Justina Wei Lynn Tan
(JWL)
Sze-Chin Tan
(SC)
Teck Choon Tan
(TC)
Claire Teo Min-Li
(CT)
Bernard Yu-Hor Thong
(BY)
Paula Permatasari Tjokrosaputro
(PP)
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Références
Rheumatology (Oxford). 2006 Aug;45(8):1023-8
pubmed: 16495318
Arthritis Care Res (Hoboken). 2013 Jul;65(7):1157-65
pubmed: 23335500
J Eur Acad Dermatol Venereol. 2011 May;25 Suppl 2:12-8
pubmed: 21388454
Ann Rheum Dis. 2010 Mar;69(3):536-41
pubmed: 19825848
Trends Immunol. 2018 Jul;39(7):562-576
pubmed: 29739666
Infect Dis Clin North Am. 2007 Sep;21(3):617-38, vii
pubmed: 17826615
Rheumatology (Oxford). 2018 Feb 1;57(2):329-336
pubmed: 29121263
Arthritis Rheum. 1988 Mar;31(3):315-24
pubmed: 3358796
J Rheumatol. 2021 Jul;48(7):992-1001
pubmed: 33262304
Ann Rheum Dis. 2020 Jun;79(6):685-699
pubmed: 31969328
Ann Rheum Dis. 2016 Jun;75(6):965-73
pubmed: 26984008
JAMA. 2001 Jul 18;286(3):327-34
pubmed: 11466099
Ann Rheum Dis. 2016 Jan;75(1):3-15
pubmed: 25969430
Medicine (Baltimore). 2017 Aug;96(34):e7896
pubmed: 28834907
Ann Rheum Dis. 2017 Jan;76(1):17-28
pubmed: 27697765
Clin Exp Rheumatol. 2015 Jan-Feb;33(1):115-21
pubmed: 25535750
Rheumatology (Oxford). 2010 Feb;49(2):295-307
pubmed: 19946022
Arthritis Care Res (Hoboken). 2015 Oct;67(10):1363-70
pubmed: 25832554
J Rheumatol. 2015 Dec;42(12):2255-60
pubmed: 26428206
Epidemiol Health. 2012;34:e2012003
pubmed: 22611518
Rheumatology (Oxford). 2011 Feb;50(2):381-8
pubmed: 21036875
QJM. 2015 Nov;108(11):853-7
pubmed: 26025688
Int J Rheum Dis. 2019 Sep;22(9):1679-1685
pubmed: 31297986
Rheumatol Int. 2013 Jul;33(7):1693-703
pubmed: 23271425
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
Arthritis Rheum. 2006 Sep;54(9):2784-92
pubmed: 16947781
Pharmacoeconomics. 2004;22(2 Suppl 1):1-12
pubmed: 15157000
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
PLoS One. 2018 Aug 24;13(8):e0203084
pubmed: 30142184
Lancet. 2002 Apr 6;359(9313):1173-7
pubmed: 11955534
Br J Rheumatol. 1994 Aug;33(8):735-9
pubmed: 8055200